Douglas E. Williams - Nov 11, 2024 Form 4 Insider Report for Climb Bio, Inc. (CLYM)

Role
Director
Signature
Emily Pimblett, as Attorney-in-Fact
Stock symbol
CLYM
Transactions as of
Nov 11, 2024
Transactions value $
$0
Form type
4
Date filed
11/12/2024, 05:47 PM
Previous filing
Nov 12, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLYM Stock Option (Right to Buy) Award $0 +20K $0.00 20K Nov 11, 2024 Common Stock 20K $4.06 Direct F1
transaction CLYM Stock Option (Right to Buy) Award $0 +6.29K $0.00 6.29K Nov 11, 2024 Common Stock 6.29K $4.06 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying the option vest in equal monthly installments from November 8, 2024 (the "Vesting Commencement Date") until the third anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service.
F2 The shares underlying the option vest on the earlier of June 26, 2025 or the day immediately prior to the next annual meeting of stockholders, subject to the Reporting Person's continued service.